Aberrant β-catenin expression and adenomatous polyposis coli gene mutation in ameloblastoma and odontogenic carcinoma

Oral Oncology

Volumn 45, Issue 2, 2009, Pages 103-108

  Siriwardena, B S M S ^a,c   Kudo, Y ^a   Ogawa, I ^b   Tilakaratne, W M ^c   Takata, T ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF PERADENIYA   (Sri Lanka)

Author keywords

Catenin; Ameloblastoma; APC; Mutation; Odontogenic tumor; Wnt

Indexed keywords

APC PROTEIN; BETA CATENIN; FORMALDEHYDE; PARAFFIN;

ADULT; AMELOBLASTOMA; ARTICLE; CLINICAL ARTICLE; COLON POLYPOSIS; DISEASE COURSE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAW CANCER; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; ODONTOGENIC CARCINOMA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAMPLE;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ADULT; AMELOBLASTOMA; BETA CATENIN; CARCINOMA, SQUAMOUS CELL; CYTOPLASM; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENES, APC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; ODONTOGENIC TUMORS;

EID: 58549119953     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.03.008     Document Type: Article

References (37)

1. In: Barnes L., Eveson J.W., Reichart P., and Sidransky D. (Eds). World health organization classification of tumors. Pathology and genetics of head and neck tumors (2005), IARC Press, Lyon 283-314
2. Heikinheimo K., Jee K.J., Niini T., Aalto Y., Happonen R.P., Leivo I., et al. Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray. J Dent Res 81 8 (2002) 525-530
3. Jääskeläinen K., Jee K.J., Leivo I., Saloniemi I., Knuutila S., and Heikinheimo K. Cell proliferation and chromosomal changes in human ameloblastoma. Cancer Genet Cytogenet 136 1 (2002) 31-37
4. Sarkar L., and Sharpe P.T. Expression of Wnt signalling pathway genes during tooth development. Mech Dev 85 1-2 (1999) 197-200
5. 2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet 16 7 (2000) 279-283
6. Polakis P. Wnt signaling and cancer. Genes Dev 14 15 (2000) 1837-1851
7. Fodde R., Smits R., and Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 1 1 (2001) 55-67
8. Taniguchi K., Roberts L.R., Aderca I.N., Dong X., Qian C., Murphy L.M., et al. Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 21 31 (2002) 4863-4871
9. Baeza N., Masuoka J., Kleihues P., and Ohgaki H. AXIN1 mutations but not deletions in cerebellar medulloblastomas. Oncogene 22 4 (2003) 632-636
10. Siriwardena B.S.M.S., Tilakaratne A., Amaratunga E.A., Udagama M.N.G.P.K., Ogawa I., Kudo Y., et al. Analysis of histopathological and immunohistochemical differences of oral squamous cell carcinoma in young and old patients in Sri Lanka. J Oral Pathol Med 36 6 (2007) 357-362
11. Kajino Y., Yamaguchi A., Hashimoto N., Matsuura A., Sato N., and Kikuchi K. Beta-catenin gene mutation in human hair follicle-related tumors. Pathol Int 51 7 (2001) 543-548
12. Giles R.H., van Es J.H., and Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653 1 (2003) 1-24
13. Moon R.T., Brown J.D., and Torres M. WNTs modulate cell fate and behavior during vertebrate development. Trends Genet 13 4 (1997) 157-162
14. Wodarz A., and Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14 (1998) 59-88
15. Behrens J., Jerchow B.A., Würtele M., Grimm J., Asbrand C., Wirtz R., et al. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280 5363 (1998) 596-599
16. Miyoshi Y., Nagase H., Ando H., Horii A., Ichii S., Nakatsuru S., et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1 4 (1992) 229-233
17. Miyaki M., Konishi M., Kikuchi-Yanoshita R., Enomoto M., Igari T., Tanaka K., et al. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 54 11 (1994) 3011-3020
18. Ikeda S., Kishida S., Yamamoto H., Murai H., Koyama S., and Kikuchi A. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J 17 5 (1998) 1371-1384
19. Itoh K., Krupnik V.E., and Sokol S.Y. Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and beta-catenin. Curr Biol 8 10 (1998) 591-594
20. Henderson B.R. Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat Cell Biol 2 9 (2000) 653-660
21. Henderson B.R., and Fagotto F. The ins and outs of APC and beta-catenin nuclear transport. EMBO Rep 3 9 (2002) 834-839
22. Rosin-Arbesfeld R., Townsley F., and Bienz M. The APC tumour suppressor has a nuclear export function. Nature 406 6799 (2000) 1009-1012
23. Nakamura Y. The adenomatous polyposis coli gene and human cancers. J Cancer Res Clin Oncol 121 9-10 (1995) 529-534
24. Nakatsuru S., Yanagisawa A., Ichii S., Tahara E., Kato Y., Nakamura Y., et al. Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Human Mol Genet 1 8 (1992) 559-563
25. Tsuchiya R., Yamamoto G., Nagoshi Y., Aida T., Irie T., and Tachikawa T. Expression of adenomatous polyposis coli (APC) in tumorigenesis of human oral squamous cell carcinoma. Oral Oncol 40 9 (2004) 932-940
26. Iwai S., Katagiri W., Kong C., Amekawa S., Nakazawa M., and Yura Y. Mutations of the APC, beta-catenin, and axin1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma. J Cancer Res Clin Oncol 131 12 (2005) 773-782
27. Kok S.H., Lee J.J., Hsu H.C., Chiang C.P., Kuo Y.S., and Kuo M.Y. Mutations of the adenomatous polyposis coli gene in areca quid and tobacco-associated oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 31 7 (2002) 395-401
28. Yap A.S., Brieher W.M., and Gumbiner B.M. Molecular and functional analysis of cadherin-based adherens junctions. Annu Rev Cell Dev Biol 13 (1997) 119-146 Review
29. Li H., Pamukcu R., and Thompson W.J. β-Catenin signaling: theraputic strategies in oncology. Cancer Biol Ther 1 6 (2002) 621-625 Review
30. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275 5307 (1997) 1787-1790
31. Ogasawara N., Tsukamoto T., Mizoshita T., Inada K., Cao X., Takenaka Y., et al. Mutations and nuclear accumulation of beta-catenin correlate with intestinal phenotypic expression in human gastric cancer. Histopathology 49 6 (2006) 612-621
32. Takayama T., Shiozaki H., Shibamoto S., Oka H., Kimura Y., Tamura S., et al. Beta-catenin expression in human cancers. Am J Pathol 148 1 (1996) 39-46
33. Lustig B., and Behrens J. The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 129 4 (2003) 199-221
34. Kikuchi A. Tumor formation by genetic mutations in the components of the Wnt signaling pathway. Cancer Sci 94 3 (2003) 225-229
35. Sekine S., Sato S., Takata T., Fukuda Y., Ishida T., Kishino M., et al. Beta-catenin mutations are frequent in calcifying odontogenic cysts, but rare in ameloblastomas. Am J Pathol 163 5 (2003) 1707-1712
36. Kawabata T., Takahashi K., Sugai M., Murashima-Suginami A., Ando S., Shimizu A., et al. Polymorphisms in PTCH1 affect the risk of ameloblastoma. J Dent Res 84 9 (2005) 812-816
37. Miyake T., Tanaka Y., Kato K., Tanaka M., Sato Y., Ijiri R., et al. Gene mutation analysis and immunohistochemical study of beta-catenin in odontogenic tumors. Pathol Int 56 12 (2006) 732-737